Renata Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RENATA, and what generic and branded alternatives to RENATA drugs are available?
RENATA has seven approved drugs.
Drugs and US Patents for Renata
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Renata | METOLAZONE | metolazone | TABLET;ORAL | 215616-001 | Oct 24, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Renata | METOLAZONE | metolazone | TABLET;ORAL | 215616-002 | Oct 24, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Renata | RISPERIDONE | risperidone | TABLET;ORAL | 078707-003 | Dec 29, 2008 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Renata | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 207062-003 | Oct 31, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.